, implies that leaving lymph nodes intact until after immunotherapy could improve efficacy against solid tumors, which now respond to only a small percentage of these newer forms of treatment. Most immunotherapies solely try to reactivate T cells in the tumor, where they frequently become fatigued fighting cancer cells as well. This can play an… Read More »